Clinical Trial Update: Bezafibrate for Hyperfibrinogenemia in Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating bezafibrate for hyperfibrinogenemia in acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Bezafibrate (bezafibrate)

Snippet

Sponsor: Instituto Mexicano del Seguro Social | Conditions: Acute Myocardial Infarction | Phase 4 | Status: COMPLETED